NEW YORK ( TheStreet) -- Shares of DUSA Pharmaceuticals (Nasdaq: DUSA) have taken a tremendous swing upward. The stock is trading at $4.02 as of 9:31 a.m. ET, 25.6% above Wednesday's closing price of $3.20. Volume is at 205,632, 5.2 times the daily average of 39,700. DUSA has a market cap of $72.4 million and is part of the health care sector and drugs industry. Shares are up 30.6% year to date as of the close of trading on Wednesday. DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally. The company has a P/E ratio of 299, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 21.5. TheStreet Ratings rates DUSA as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full DUSA Ratings Report. See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.